Home Amines 625115-52-8
625115-52-8,MFCD22741546
Catalog No.:AA00ECBA

625115-52-8 | Methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)carbamate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥95%
in stock  
$123.00   $86.00
- +
10mg
95%
in stock  
$216.00   $152.00
- +
25mg
≥95%
in stock  
$362.00   $253.00
- +
50mg
95%
in stock  
$432.00   $303.00
- +
100mg
95%
in stock  
$695.00   $486.00
- +
200mg
95%
in stock  
$911.00   $638.00
- +
500mg
95%
in stock  
$1,188.00   $832.00
- +
1g
95%
in stock  
$1,497.00   $1,048.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00ECBA
Chemical Name:
Methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)carbamate
CAS Number:
625115-52-8
Molecular Formula:
C19H17FN8O2
Molecular Weight:
408.3891
MDL Number:
MFCD22741546
SMILES:
COC(=O)Nc1c(N)nc(nc1N)c1nn(c2c1cccn2)Cc1ccccc1F
Properties
Computed Properties
 
Complexity:
589  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
30  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
5  
XLogP3:
1.4  

Literature

Title: Combination of BAY 60-4552 and vardenafil exerts proerectile facilitator effects in rats with cavernous nerve injury: a proof of concept study for the treatment of phosphodiesterase type 5 inhibitor failure.

Journal: European urology 20111101

Title: Are we finally on the right track in treating 'difficult' erectile dysfunction patients?

Journal: European urology 20111101

Title: Costell MH, et al. Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stress. Front Pharmacol. 2012 Jul 5;3:128.

Title: Zhao X, et al. Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator Riociguat in Healthy Young Chinese Male Non-Smokers and Smokers: Results of a Randomized, Double-Blind, Placebo-Controlled Study. Clin Pharmacokinet. 2016 May;55(5):615-24.

Title: Oudot A, et al. Combination of BAY 60-4552 and vardenafil exerts proerectile facilitator effects in rats with cavernous nerve injury: a proof of concept study for the treatment of phosphodiesterase type 5 inhibitor failure. Eur Urol. 2011 Nov;60(5):1020-6.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:625115-52-8 Molecular Formula|625115-52-8 MDL|625115-52-8 SMILES|625115-52-8 Methyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)carbamate